In designing thermally activated delayed fluorescence (TADF) emitters, a high reverse intersystem crossing (RISC) rate with a high photoluminescence quantum yield is essential. Herein, two blue TADF molecules, 2′,5′-di(9H-carbazol-9-yl)-3′,6′-bis(3,6-ditert-butyl-9H-carbazol-9-yl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarbonitrile (CzTCzPhBN) and 2′,5′-bis(3,6-ditert-butyl-9H-carbazol-9-yl)-3′,6′-bis(3,6-diphenyl-9H-carbazol-9-yl)-[1,1′:4′,1″-terphenyl]-4,4″-dicarbonitrile (PhCzTCzPhBN) with a high RISC rate, were developed through donor engineering. CzTCzPhBN and PhCzTCzPhBN showed a high RISC rate of 4.00 × 105 and 16.62 × 105 s–1, respectively, with a high photoluminescence quantum yield of 80.1 and 84.9%, which resulted in high external quantum efficiency of 27.0 and 27.8% with color coordinates (0.148, 0.170) and (0.150, 0.230) in blue TADF organic light-emitting diodes, respectively. The high RISC rate and device efficiency inspired two TADF molecules to be used as sensitizers in hyperfluorescence devices. The hyperfluorescence devices showed ultra-high external quantum efficiency of 30.7 and 36.4% with color coordinates (0.125, 0.164) and (0.127, 0.193), respectively.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: